OTLK | Outlook TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$0.46
-$0.01 (-1.96%)

Outlook Therapeutics (OTLK) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.

The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $0.46 vs 50 $0.59 / 200 $0.66
Projection
No cross projected
Test
No active test
Last cross
Death cross 19 Oct 2026 ยท projected 17 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $0.47 vs 50 $0.81 / 200 $7.53
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 13:30 ET

Price
below both $0.47 vs 50 $0.54 / 200 $0.93
Projection
No cross projected
Test
No active test
Last cross
Death cross 31 Aug 2026 ยท projected 29 bars out

Cross history

32
crosses on record since 2020
16 golden16 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
19 Oct 2026Death steepdaily17 bars outNot tested
31 Aug 2026Death4-hour29 bars outNot tested
14 Jul 2026Golden steepdaily21 bars outNot tested
4 Jun 2026Golden4-hour12 bars outNot tested
16 Jan 2026Death4-hour29 bars outNot tested

About OTLK

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$10.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandmicro

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.